LEGN logo

Legend Biotech (LEGN)

Profile

Full Name

Legend Biotech Corporation

Ticker Symbol

LEGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 5, 2020

Indexes

Not included

Website

http://www.legendbiotech.com

Employees

2600

Key Details

Price

$32.00(+2.30%)

Market cap

$5.88B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$627.24M(+119.97% YoY)

Annual EPS

-$0.96(+67.35% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$32.00
LEGN price is $32.00

30-Day Relative Volume

1.27
LEGN 30-day relative volume is 1.27

Price Performance

Price Most recent change

+2.3%
LEGN price was up +2.3% on Apr 11, 2025

Price YTD change

-1.66%
LEGN price is down -1.66% since January 1st

Price 1-year change

-41.83%
LEGN price is down -41.83% year-on-year

Price 3-year change

-21.34%
LEGN price is down -21.34% over the past 3 years

Price Range

Price All-time high

$77.32
LEGN price is currently -58.61% below its historical high of $77.32

Price 3-year low

$29.27
LEGN price is currently +9.35% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$5.88B
LEGN market capitalization is $5.88 billion

Market cap 3-year change

-6.64%
LEGN market capitalization is down -6.64% over the past 3 years

Market cap All-time high

$13.96B
LEGN market capitalization is currently -57.92% below its historical high of $13.96 billion

Market cap sector rank

90.14%
LEGN market capitalization is higher than 90.14% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.75%
LEGN shares outstanding is up +0.75% year-on-year

Shares Outstanding 3-Year Change

+18.69%
LEGN shares outstanding is up +18.69% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.49
LEGN beta is 0.49

200-day SMA

$43.16
LEGN price is currently -25.86% below its 200-day simple moving average

50-day SMA

$35.60
LEGN price is currently -10.12% below its 50-day simple moving average

RSI

42.00
LEGN 14-day relative strength index is 42.00

Volume

1.27
LEGN 30-day relative volume is 1.27

ATR

$1.83
LEGN average true range is $1.83

10-day Historical Volatility

65.82%
LEGN 10-day historical volatility is 65.82%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$627.24M
LEGN annual revenue is $627.24 million

Revenue Analysts estimate

$1.03B
LEGN annual revenue is currently -38.88% lower than the consensus analysts' forecast

Revenue 1-year change

+119.97%
LEGN annual revenue is up +119.97% year-on-year

Revenue Sector rank

75.92%
LEGN annual revenue is higher than 75.92% of companies in Healthcare sector

EPS

EPS

-$0.96
LEGN annual earnings per share is -$0.96

EPS Analysts estimate

-$0.70
LEGN annual earnings per share is currently +37.14% higher than the consensus analysts' forecast

EPS 1-year change

+67.35%
LEGN annual earnings per share is up +67.35% year-on-year

EPS Sector rank

57.39%
LEGN annual earnings per share is higher than 57.39% of companies in Healthcare sector

Profit

Gross profit

$392.66M
LEGN annual gross profit is $392.66 million

Gross margin

62.60%
LEGN annual gross profit margin is 62.60%

Operating profit

-$303.24M
LEGN annual operating income is -$303.24 million

Operating margin

-48.35%
LEGN annual operating profit margin is -48.35%

Net income

-$177.03M
LEGN annual net profit is -$177.03 million

Net margin

-28.22%
LEGN annual net profit margin is -28.22%

Expenses

Total expenses

$930.48M
LEGN annual total expenses is $930.48 million

Operating expenses

$695.90M
LEGN annual total operating expenses is $695.90 million

Cost of goods sold

$234.58M
LEGN annual cost of goods sold is $234.58 million

Selling, general & administrative expenses

$284.26M
LEGN annual SGA is $284.26 million

Depreciation and amortization

$23.36M
LEGN annual depreciation & amortization is $23.36 million

Interest expense

$21.61M
LEGN annual interest expense is $21.61 million

Income tax

$18.89M
LEGN annual income tax is $18.89 million

EBIT & EBITDA

EBIT

-$136.52M
LEGN annual earnings before interest & taxes is -$136.52 million

EBITDA

-$113.16M
LEGN annual EBITDA is -$113.16 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.67B
LEGN annual total assets is $1.67 billion

Non current assets

$386.24M
LEGN annual long term assets is $386.24 million

Current assets

$1.28B
LEGN annual total current assets is $1.28 billion

Cash and cash equivalents

$286.75M
LEGN annual cash & cash equivalents is $286.75 million

Accounts receivable

$6.29M
LEGN annual accounts receivable is $6.29 million

Inventory

$23.90M
LEGN annual inventory is $23.90 million

Liabilities

Total liabilities

$629.61M
LEGN annual total liabilities is $629.61 million

Long term liabilities

$351.96M
LEGN annual total long term liabilities is $351.96 million

Current liabilities

$277.64M
LEGN annual total current liabilities is $277.64 million

Accounts payable

$37.19M
LEGN annual accounts payable is $37.19 million

Debt

Total debt

$350.60M
LEGN annual total debt is $350.60 million

Total debt 1-year change

+6.67%
LEGN annual total debt is up +6.67% year-on-year

Long term debt

$345.81M
LEGN annual long term debt is $345.81 million

Short term debt

$4.79M
LEGN annual short term debt is $4.79 million

Equity & Capital

Shareholders equity

$1.04B
LEGN annual stockholders equity is $1.04 billion

Book value

$1.04B
LEGN annual book value is $1.04 billion

Retained earnings

-$1.66B
LEGN annual retained earnings is -$1.66 billion

Working capital

$1.01B
LEGN annual working capital is $1.01 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$144.03M
LEGN annual cash flow from operations is -$144.03 million

Cash from operations 1-year change

+63.38%
LEGN annual cash flow from operations is up +63.38% year-on-year

Cash from investing

-$850.54M
LEGN annual cash flow from investing activities is -$850.54 million

Cash from investing 1-year change

-1016.67%
LEGN annual cash flow from investing activities is down -1016.67% year-on-year

Cash from financing

$5.70M
LEGN annual cash flow from financing activities is $5.70 million

Cash from financing 1-year change

-99.28%
LEGN annual cash flow from financing activities is down -99.28% year-on-year

CAPEX

CAPEX

$14.11M
LEGN annual capital expenditures is $14.11 million

CAPEX 1-year change

-37.92%
LEGN annual capital expenditures is down -37.92% year-on-year

Free Cash Flow

Free cash flow

-$158.14M
LEGN annual free cash flow is -$158.14 million

Free cash flow 1-year change

+61.99%
LEGN annual free cash flow is up +61.99% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

62.60%
LEGN annual gross profit margin is 62.60%

Operating margin

-48.35%
LEGN annual operating profit margin is -48.35%

Net margin

-28.22%
LEGN annual net profit margin is -28.22%

ROA & ROE

ROA

-10.06%
LEGN annual return on assets is -10.06%

ROE

-15.45%
LEGN annual return on equity is -15.45%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
LEGN price to earnings ratio value is unknown

PE ratio Sector rank

-
LEGN price to earnings ratio is unknown

PB Ratio

PB ratio

5.65
LEGN price to book ratio is 5.65

PB ratio Sector rank

85.44%
LEGN price to book ratio is higher than 85.44% of companies in Healthcare sector

PS Ratio

PS ratio

9.37
LEGN price to sales ratio is 9.37

PS ratio Sector rank

78.59%
LEGN price to sales ratio is higher than 78.59% of companies in Healthcare sector

Enterprise value

Enterprise value

$5.94B
LEGN enterprise value is $5.94 billion

Enterprise value Sector rank

89.28%
LEGN enterprise value is higher than 89.28% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-52.50
LEGN EV/EBITDA is -52.50

EV/EBITDA Sector rank

2.34%
LEGN EV/EBITDA is higher than 2.34% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.62
LEGN annual current ratio is 4.62

Quick ratio

4.54
LEGN annual quick ratio is 4.54

Leverage

Debt to equity

0.29
LEGN annual debt to equity ratio is 0.29

Interest coverage ratio

-6.32
LEGN annual interest coverage ratio is -6.32

Risk & Stability

Piotroski F-Score

3
LEGN piotroski f-score is 3

Altman Z-Score

5.04
LEGN altman z-score is 5.04

Analyst ratings

Recent major analysts updates

Apr 8, 25 HC Wainwright & Co.
Buy
Mar 17, 25 Morgan Stanley
Overweight
Mar 12, 25 HC Wainwright & Co.
Buy
Mar 12, 25 Guggenheim
Neutral
Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Jan 21, 25 HC Wainwright & Co.
Buy
Dec 30, 24 Piper Sandler
Overweight
Dec 10, 24 HC Wainwright & Co.
Buy
Dec 9, 24 RBC Capital
Outperform

Institutional Ownership

Similar stocks

BRKR logo
Bruker (BRKR)
STVN logo
Stevanato Group SpA (STVN)
TGTX logo
TG Therapeutics (TGTX)
TFX logo
Teleflex Incorporated (TFX)
JAZZ logo
Jazz Pharmaceuticals (JAZZ)
Telix Pharmaceuticals Limited (TLX)
MMSI logo
Merit Medical Systems (MMSI)
GH logo
Guardant Health (GH)
WAY logo
Waystar Holding (WAY)
  • What is the ticker symbol for Legend Biotech?
  • Does Legend Biotech pay dividends?
  • What sector is Legend Biotech in?
  • What industry is Legend Biotech in?
  • What country is Legend Biotech based in?
  • When did Legend Biotech go public?
  • Is Legend Biotech in the S&P 500?
  • Is Legend Biotech in the NASDAQ 100?
  • Is Legend Biotech in the Dow Jones?
  • When was Legend Biotech's last earnings report?
  • When does Legend Biotech report earnings?
  • Should I buy Legend Biotech stock now?

What is the ticker symbol for Legend Biotech?

The ticker symbol for Legend Biotech is NASDAQ:LEGN

Does Legend Biotech pay dividends?

No, Legend Biotech does not pay dividends

What sector is Legend Biotech in?

Legend Biotech is in the Healthcare sector

What industry is Legend Biotech in?

Legend Biotech is in the Biotechnology industry

What country is Legend Biotech based in?

Legend Biotech is headquartered in United States

When did Legend Biotech go public?

Legend Biotech's initial public offering (IPO) was on June 5, 2020

Is Legend Biotech in the S&P 500?

No, Legend Biotech is not included in the S&P 500 index

Is Legend Biotech in the NASDAQ 100?

No, Legend Biotech is not included in the NASDAQ 100 index

Is Legend Biotech in the Dow Jones?

No, Legend Biotech is not included in the Dow Jones index

When was Legend Biotech's last earnings report?

Legend Biotech's most recent earnings report was on Mar 11, 2025

When does Legend Biotech report earnings?

The next expected earnings date for Legend Biotech is May 13, 2025

Should I buy Legend Biotech stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page